Literature DB >> 32242260

Knocking out matrix metalloproteinase 12 causes the accumulation of M2 macrophages in intestinal tumor microenvironment of mice.

Mingming Yang1, Xiaohan Zhang2, Qing Liu1, Ting Niu1, Lingbi Jiang1, Haobin Li1, Jianbiao Kuang1, Cuiling Qi1, Qianqian Zhang1, Xiaodong He1, Lijing Wang1, Jiangchao Li3.   

Abstract

MMP12 is mainly secreted by macrophages, is involved in macrophage development, and decomposes the extracellular matrix. Herein, we investigated whether macrophages would change in the intestinal tumor microenvironment after MMP12 knockout. ApcMin/+;MMP12-/-mice were obtained by crossbreeding ApcMin/+ mice with MMP12 knockout mice (MMP12-/- mice). The data showed that the number and volume of intestinal tumors were significantly increased in ApcMin/+;MMP12-/- mice compared with ApcMin/+ mice. Additionally, the tumor biomarkers CA19-9, CEA, and β-catenin appeared relatively early in intestinal tumors in ApcMin/+;MMP12-/- mice. The results demonstrated that knocking out MMP12 accelerated the tumor growth and pathological process. On further investigation of its mechanism, the proportions of M2 macrophages in the spleen and among peritoneal macrophages were significantly up-regulated in ApcMin/+;MMP12-/- mice. Expression of M2 macrophage-related genes was up-regulated in tumor and peritoneal macrophages. The M2-related cytokine levels of IL-4 and IL-13 were increased in the serum of ApcMin/+;MMP12-/-mice. In vitro, bone marrow-derived M2 macrophages were obtained by treating bone marrow cells with IL-4 and IL-13, and these M2 macrophages secreted cytokines being changed. This finding reveals the crucial role of MMP12 in macrophage development and provides a new target for the control of macrophage polarization. Knocking out MMP12 causes intestinal M2 macrophage accumulation in tumor microenvironment, promoting the growth of intestinal tumors in ApcMin/+ mice.

Entities:  

Keywords:  ApcMin/+ mice; M2 macrophage; MMP12; Tumor growth

Year:  2020        PMID: 32242260     DOI: 10.1007/s00262-020-02538-3

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  4 in total

1.  DRP1 contributes to head and neck cancer progression and induces glycolysis through modulated FOXM1/MMP12 axis.

Authors:  Tai-Lin Huang; Chuang-Rung Chang; Chih-Yen Chien; Gong-Kai Huang; Yi-Fan Chen; Li-Jen Su; Hsin-Ting Tsai; Yu-Sheng Lin; Fu-Min Fang; Chang-Han Chen
Journal:  Mol Oncol       Date:  2022-04-15       Impact factor: 7.449

2.  An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma.

Authors:  Chaoqi Zhang; Guochao Zhang; Nan Sun; Zhen Zhang; Liyan Xue; Zhihui Zhang; Haijun Yang; Yuejun Luo; Xiaoli Zheng; Yonglei Zhang; Yufen Yuan; Ruixue Lei; Zhaoyang Yang; Bo Zheng; Le Wang; Yun Che; Feng Wang; Sihui Wang; Shugeng Gao; Qi Xue; Yi Zhang; Jie He
Journal:  Signal Transduct Target Ther       Date:  2020-09-04

3.  MMP12 is a potential therapeutic target for Adamantinomatous craniopharyngioma: Conclusions from bioinformatics analysis and in vitro experiments.

Authors:  Minde Li; Lin Zhou; Shaoyang Li; Linchun Fang; Le Yang; Xiao Wu; Chenxing Yang; Youyuan Bao; Sihai Lan; Zhigao Tong; Suyue Zheng; Bin Tang; Erming Zeng; Shenhao Xie; Cheng Chen; Tao Hong
Journal:  Oncol Lett       Date:  2021-05-19       Impact factor: 2.967

4.  MMP12 knockout prevents weight and muscle loss in tumor-bearing mice.

Authors:  Lingbi Jiang; Mingming Yang; Shihui He; Zhengyang Li; Haobin Li; Ting Niu; Dehuan Xie; Yan Mei; Xiaodong He; Lili Wei; Pinzhu Huang; Mingzhe Huang; Rongxin Zhang; Lijing Wang; Jiangchao Li
Journal:  BMC Cancer       Date:  2021-12-04       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.